PATH vs POCI · P/E 19, rev $1.61B vs rev $19.1M
Uipath Inc (PATH) versus Precision Optics Corporation, Inc. Common stock (POCI) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Precision Optics Corporation, Inc. Common stock (POCI) is a medical instruments & supplies company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported POCI revenue for 2025-06-30 was $19.1M. Net income was -$5.8M. Revenue was down 0.1% from 2024-06-30 to 2025-06-30. POCI currently screens at market cap $63.4M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. POCI currently screens at market cap $63.4M.
Not investment advice. Open the PATH and POCI stock pages for the full models.
Not investment advice.